The DOI matches its Crossref record, with a small difference in title or year; 61 of the 62 references it cites were found in a registry or an index.
Impact of Lipids on Cardiovascular Health
Open accessAbstract
People who maintain ideal cardiovascular heath have a low lifetime risk of cardiovascular disease. Therefore, encouraging people to achieve ideal cardiovascular health represents an important opportunity to improve the prevention of cardiovascular disease. However, preventing cardiovascular disease by promoting ideal cardiovascular health requires shifting the focus from treating disease after it develops to preventing cardiovascular events before they happen by slowing the progression of atherosclerosis. Because atherogenic lipoproteins play a central causal role in the initiation and progression of atherosclerosis, maintaining optimal lipid levels is necessary to achieve ideal cardiovascular health. This review describes the cumulative effect of lipid-carrying lipoproteins on the risk of cardiovascular disease, estimates the magnitude of the clinical benefit that can be achieved by maintaining optimal lipid levels, identifies the most effective timing for implementing strategies designed to achieve optimal lipid levels, and provides a clinical pathway to help people achieve the lipid levels necessary for ideal cardiovascular health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ApoB-containing lipoproteins retained in the arterial wall provoke a complex process that leads to lipid deposition and the initiation of an atheroma [43].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Self-citationGeneral Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Self-citationA Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
Cited by
Sorted by citations
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Self-citationArnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.010 · Cited by 1,896
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Self-citation2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.009 · Cited by 1,193
(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk
Domanski, M. J., Tian, X., Wu, C. O., Reis, J. P., Dey, A. K., Gu, Y., Zhao, L., Bae, S., Liu, K., Hasan, A. A., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.059 · Cited by 411
Ye, Z., Hu, T., Wang, J., Xiao, R., Liao, X., Liu, M., & Sun, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.933913 · Cited by 341
Zhang, Y., Pletcher, M. J., Vittinghoff, E., Clemons, A. M., Jacobs, D. R., Allen, N. B., Alonso, A., Bellows, B. K., Oelsner, E. C., Zeki Al Hazzouri, A., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.3508 · Cited by 257
Roeters van Lennep, J. E., Tokgözoğlu, L. S., Badimon, L., Dumanski, S. M., Gulati, M., Hess, C. N., Holven, K. B., Kavousi, M., Kayıkçıoğlu, M., Lutgens, E., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad472 · Cited by 229
The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis
Vourakis, M., Mayer, G., & Rousseau, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158074 · Cited by 233
Ruscica, M., Ferri, N., Banach, M., Sirtori, C. R., & Corsini, A. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac020 · Cited by 218
Wang, N., Fulcher, J., Abeysuriya, N., Park, L., Kumar, S., Di Tanna, G. L., Wilcox, I., Keech, A., Rodgers, A., & Lal, S. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30388-2 · Cited by 187
The LDL cumulative exposure hypothesis: evidence and practical applications
Ference, B. A., Braunwald, E., & Catapano, A. L. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01039-5 · Cited by 196
Self-citationSex differences in lipids: a life course approach
Holven, K. B., & Roeters van Lennep, J. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117270 · Cited by 180
Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu)
Tian, K., Li, J., & Xu, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.019 · Cited by 178
Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy
Vinci, P., Panizon, E., Tosoni, L. M., Cerrato, C., Pellicori, F., Mearelli, F., Biasinutto, C., Fiotti, N., Girolamo, F. G. D., & Biolo, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111687 · Cited by 188
Ray, K. K., Stoekenbroek, R. M., Kallend, D., Nishikido, T., Leiter, L. A., Landmesser, U., Wright, R. S., Wijngaard, P. L. J., & Kastelein, J. J. P. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3502 · Cited by 172
Kronenberg, F., Mora, S., Stroes, E. S. G., Ference, B. A., Arsenault, B. J., Berglund, L., Dweck, M. R., Koschinsky, M. L., Lambert, G. C., Mach, F., et al. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.04.012 · Cited by 146
Self-citationKris‐Etherton, P. M., & Krauss, R. M. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa110 · Cited by 145
PCSK9 inhibition and inflammation: A narrative review
Ruscica, M., Tokgözoğlu, L. S., Corsini, A., & Sirtori, C. R. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.07.015 · Cited by 133
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Self-citationMakover, M. E., Shapiro, M. D., & Toth, P. P. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100371 · Cited by 139
Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years
Mendieta, G., Pocock, S., Mass, V., Moreno, A. D., Owen, R., García‐Lunar, I., López‐Melgar, B., Fuster, J. J., Andrés, V., Pérez-Herreras, C., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.09.814 · Cited by 125
Chinese Guideline on the Primary Prevention of Cardiovascular Diseases
Chinese Society of Cardiology of Chinese Medical Association, C. D. P. A. R. C. O. C. A. O. R. M. (2021) · Cardiology Discovery · doi:10.1097/cd9.0000000000000025 · Cited by 109
New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B
Nurmohamed, N. S., Návar, A. M., & Kastelein, J. J. P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.079 · Cited by 116
A new dawn for managing dyslipidemias: The era of rna-based therapies
Macchi, C., Sirtori, C. R., Corsini, A., Santos, R. D., Watts, G. F., & Ruscica, M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104413 · Cited by 95
Georgakis, M. K., Malik, R., Anderson, C. D., Parhofer, K. G., Hopewell, J. C., & Dichgans, M. (2019) · Brain · doi:10.1093/brain/awz413 · Cited by 91
Familial Hypercholesterolemia: Global Burden and Approaches
Tokgözoğlu, L. S., & Kayıkçıoğlu, M. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01565-5 · Cited by 97
Age and sex are associated with the plasma lipidome: findings from the GOLDN study
Slade, E., Irvin, M. R., Xie, K., Arnett, D. K., Claas, S. A., Kind, T., Fardo, D. W., & Graf, G. A. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01456-2 · Cited by 83
The Role of the Gut Microbiota on the Beneficial Effects of Ketogenic Diets
Attaye, I., van Oppenraaij, S. L., Warmbrunn, M. V., & Nieuwdorp, M. (2021) · Nutrients · doi:10.3390/nu14010191 · Cited by 85
An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease
Koren, M. J., Rodriguez, F., East, C., Toth, P. P., Watwe, V., Abbas, C. A., Sarwat, S., Kleeman, K., Kumar, B., Ali, Y., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.03.382 · Cited by 81
Zou, J., Wang, J., Ye, W., Lü, J., Li, C., Zhang, D., Ye, W., Xu, S., Chen, C., Liu, P., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113626 · Cited by 80
Zhang, K., Wang, H., He, W., Chen, G., Lu, P., Xu, R., Yu, P., Ye, T., Guo, S., Li, S., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.141648 · Cited by 77
Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors
Preiss, D., Tobert, J. A., Hovingh, G. K., & Reith, C. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.072 · Cited by 75
Macchi, C., Banach, M., Corsini, A., Sirtori, C., Ferri, N., & Ruscica, M. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319831500 · Cited by 78
An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia
Koren, M. J., Vega, R. B., Agrawal, N., Xu, Y., Barbour, A., Yu, H., Wallerstedt, E., Carter, D., Middlemiss, J. E., Twaddle, L., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.03.499 · Cited by 77
Glycaemic Control and Vascular Complications in Diabetes Mellitus Type 2
Maranta, F., Cianfanelli, L., & Cianflone, D. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_514 · Cited by 74
Wilkinson, M. J., Lepor, N. E., & Michos, E. D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028892 · Cited by 70
Marked plaque regression in homozygous familial hypercholesterolemia
Reeskamp, L. F., Nurmohamed, N. S., Bom, M. J., Planken, R. N., Driessen, R. S., van Diemen, P. A., Luirink, I. K., Groothoff, J. W., Kuipers, I. M., Knaapen, P., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.04.014 · Cited by 69
Escobar, C., Anguita, M. P., Arrarte, V., Barrios, V., Cequier, A. R., Cosı́n-Sales, J., Egocheaga, I., de Sá, E. L., Masana, L., Pallarés‐Carratalá, V., et al. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.07.024 · Cited by 65
Garlic: A systematic review of the effects on cardiovascular diseases
Imaizumi, V. M., Laurindo, L. F., Manzan, B., Guiguer, É. L., Oshiiwa, M., Otoboni, A. M. M. B., Araújo, A. C., Tofano, R. J., & Barbalho, S. M. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2043821 · Cited by 68
Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy
Sosnowska, B., Surma, S., & Banach, M. (2022) · Pharmaceuticals · doi:10.3390/ph15121573 · Cited by 64
Systematic Coronary Risk Evaluation (SCORE)
Graham, I. M., Angelantonio, E. D., Visseren, F. L. J., Bacquer, D. D., Ference, B. A., Timmis, A., Halle, M., Vardas, P. E., Huculeci, R., & Cooney, M. T. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.052 · Cited by 60
Self-citationWang, H., Zhang, H., & Zou, Z. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002741 · Cited by 63
Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices
Thongtang, N., Sukmawan, R., Llanes, E. J. B., & Lee, Z.-V. (2022) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2022.101819 · Cited by 61
Lee, H., Park, J.-B., Hwang, I.-C., Yoon, Y. E., Park, H. E., Choi, S.-Y., Kim, Y.-J., Cho, G.-Y., Han, K., & Kim, H.-K. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319898571 · Cited by 56
Gencer, B., Bonomi, M., Adorni, M. P., Sirtori, C. R., Mach, F., & Ruscica, M. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09628-2 · Cited by 58
Ruscica, M., Banach, M., Sahebkar, A., Corsini, A., & Sirtori, C. R. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1583209 · Cited by 56
Daiber, A., Frenis, K., Kuntić, M., Li, H., Wolf, E., Kilgallen, A. B., Lecour, S., Laake, L. W. V., Schulz, R., Hahad, O., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0272 · Cited by 58
Public health guidelines should recommend reducing saturated fat consumption as much as possible: NO
Krauss, R. M., & Kris‐Etherton, P. M. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa111 · Cited by 54
Rikhi, R. R., Hammoud, A., Ashburn, N. P., Snavely, A. C., Michos, E. D., Chevli, P. A., Tsai, M. Y., Herrington, D. M., & Shapiro, M. D. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.10.004 · Cited by 52
Monomeric C-Reactive Protein in Atherosclerotic Cardiovascular Disease: Advances and Perspectives
Melnikov, I., Kozlov, S. G., Saburova, O., Avtaeva, Y., Guria, K. G., & Ахнафович, Г. З. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032079 · Cited by 56
Albosta, M. S., Grant, J. K., Taub, P., Blumenthal, R. S., Martin, S. S., & Michos, E. D. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s338424 · Cited by 51
Roberts, R., Chang, C. C., & Hadley, T. D. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.09.004 · Cited by 54
Abera, A., Worede, A., Hirigo, A. T., Alemayehu, R., & Ambachew, S. (2024) · European journal of medical research · doi:10.1186/s40001-024-01802-x · Cited by 48
Wu, Z., Huang, Z., Lichtenstein, A. H., Liu, Y., Chen, S., Jin, Y., Na, M., Bao, L., Wu, S., & Gao, X. (2021) · BMC Medicine · doi:10.1186/s12916-021-02014-4 · Cited by 46
Park, J., Kim, D. H., Lee, H., Hwang, I., Yoon, Y. E., Park, H. E., Choi, S., Kim, Y.-J., Cho, G., Han, K., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.315705 · Cited by 46
Statin therapy for the primary prevention of cardiovascular disease: Pros
Razavi, A. C., Mehta, A., & Sperling, L. S. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.07.004 · Cited by 42
Bolli, A., Domenico, P. D., Pastorino, R., Busby, G., & Bottà, G. (2021) · Circulation · doi:10.1161/circulationaha.120.051843 · Cited by 44
Psidium guajava L.: A Systematic Review of the Multifaceted Health Benefits and Economic Importance
Takeda, L. N., Laurindo, L. F., Guiguer, É. L., Bishayee, A., Araújo, A. C., Úbeda, L. C. C., Goulart, R. D. Á., & Barbalho, S. M. (2022) · Food Reviews International · doi:10.1080/87559129.2021.2023819 · Cited by 44
Zhou, Z., Ong, K. L., Whelton, S. P., Allison, M., Curtis, A. J., Blaha, M. J., Breslin, M. C., Tonkin, A. M., Magnussen, C. G., Budoff, M. J., et al. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.03.025 · Cited by 41
Tragni, E., Vigna, L., Ruscica, M., Macchi, C., Casula, M., Santelia, A., Catapano, A. L., & Magni, P. (2021) · Nutrients · doi:10.3390/nu13061804 · Cited by 44
Self-citationHao, D., Danbin, W., Maojuan, G., Chun, S., Bin, L., Yang, L., Yingxin, S., Guanwei, F., Chen, Y., Gao, Q., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104306 · Cited by 40
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?
Carugo, S., Sirtori, C. R., Corsini, A., Tokgözoğlu, L. S., & Ruscica, M. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01074-y · Cited by 40
Marquina, C., Lacaze, P. A., Tiller, J. M., Riaz, M., Sturm, A. C., Nelson, M. R., Ference, B. A., Pang, J., Watts, G. F., Nicholls, S. J., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab770 · Cited by 41
Self-citationZhang, Y., Du, M., Wang, J., & Liu, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.828161 · Cited by 38
Redefining cardiovascular risk prediction: is the crystal ball clearer now?
Tokgözoğlu, L. S., & Torp-Pedersen, C. T. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab310 · Cited by 41
Roessler, J., Leistner, D. M., Landmesser, U., & Haghikia, A. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.08.018 · Cited by 39
Harnessing RNA Interference for Cholesterol Lowering: The Bench‐to‐Bedside Story of Inclisiran
Wilkinson, M. J., Bajaj, A., Brousseau, M. E., & Taub, P. R. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032031 · Cited by 37
Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies
Malick, W. A., Waksman, O., Do, R., Köenig, W., Pradhan, A. D., Stroes, E. S. G., & Rosenson, R. S. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.02.034 · Cited by 38
Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life
Nielsen, S. T., Lytsen, R. M., Strandkjær, N., Rasmussen, I. J., Sillesen, A., Vøgg, R. O. B., Raja, A. A., Nordestgaard, B. G., Kamstrup, P. R., Iversen, K. K., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad547 · Cited by 38
Sex Differences in Familial Hypercholesterolemia
Klevmoen, M., Mulder, J. W. C. M., van Lennep, J. E. R., & Holven, K. B. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01155-6 · Cited by 38
Veturi, Y., Lucas, A., Bradford, Y., Hui, D., DUDEK, S. M., Theusch, E., Verma, A., Miller, J. E., Kullo, I. J., Hakonarson, H. H., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00879-y · Cited by 32
Cardiovascular Risk Estimation and Stratification Among Individuals with Hypercholesterolemia
Bosco, G., Mszar, R., Piro, S., Sabouret, P. F., & Gallo, A. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01225-3 · Cited by 39
2022 Taiwan lipid guidelines for primary prevention
Huang, P., Lu, Y., Tsai, Y., Wu, Y., Li, H., Chang, H.-Y., Wu, C., Yang, C., Tarng, D., Huang, C., et al. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2022.05.010 · Cited by 37
Langsted, A., & Nordestgaard, B. G. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000681 · Cited by 33
Bilitou, A., Were, J., Farrer, A., Rabe, A., Ming, S. W. Y., Haq, I., & Dunton, K. (2022) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s347085 · Cited by 34
Chen, Z., Mo, J., Xu, J., Wang, A., Dai, L., Cheng, A., Yalkun, G., Meng, X., Zhao, X., Li, H., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa052 · Cited by 35
The Cardiac Lipidome in Models of Cardiovascular Disease
Tomczyk, M. M., & Dolinsky, V. W. (2020) · Metabolites · doi:10.3390/metabo10060254 · Cited by 33
Plant Stanol Esters Reduce LDL (Low-Density Lipoprotein) Aggregation by Altering LDL Surface Lipids
Ruuth, M. K., Äikäs, L., Tigistu‐Sahle, F., Käkelä, R., Lindholm, H. J., Simonen, P. P., Kovanen, P. T., Gylling, H., & Öörni, K. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314329 · Cited by 32
Cumulative burden of lipid profiles predict future incidence of ischaemic stroke and residual risk
Dai, L., Xu, J., Zhang, Y., Wang, A., Chen, Z., Mo, J., Li, H., Meng, X., Wu, S., & Wang, Y. (2021) · Stroke and Vascular Neurology · doi:10.1136/svn-2020-000726 · Cited by 33
Xu, S., Qin, Z., Yuan, R., Cui, X., Zhang, L., Bai, J., Liu, G., Wang, Z., Yu, F., Lv, Y., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.992252 · Cited by 31
Christensen, J. J., Arnesen, E., Rundblad, A., Telle‐Hansen, V. H., Narverud, I., Blomhoff, R., Bogsrud, M. P., Retterstøl, K., Ulven, S. M., & Holven, K. B. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117433 · Cited by 31
Øyri, L. K. L., Bogsrud, M. P., Christensen, J. J., Ulven, S. M., Brantsæter, A. L., Retterstøl, K., Brekke, H. K., Michelsen, T. M., Henriksen, T., van Lennep, J. E. R., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-01959-w · Cited by 31
Zhang, Y., Feng, X., Du, M., Ding, J., & Liu, P. (2022) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320221079468 · Cited by 31
Zhao, L., Chu, X.-H., Liu, S., Li, R., Zhu, Y., Li, F.-N., Jiang, J., Zhou, J., Lei, X. G., & Sun, L. (2022) · Journal of Nutrition · doi:10.1093/jn/nxac141 · Cited by 31
Efficacy and Safety of Inclisiran in Asian Patients
Huo, Y., Lesogor, A., Lee, C. W., Chiang, C.-E., Mena-Madrazo, J., Poh, K. K., Jeong, M. H., Maheux, P., Zhang, M., Wei, S., et al. (2024) · JACC: Asia · doi:10.1016/j.jacasi.2023.09.006 · Cited by 31
Hirsh, S. P., Pons, M., Joyal, S. V., & Swick, A. G. (2019) · Journal of Nutritional Science · doi:10.1017/jns.2019.8 · Cited by 28
Effects of Lipoproteins on Metabolic Health
Albitar, O., D’Souza, C. M., & Adeghate, E. A. (2024) · Nutrients · doi:10.3390/nu16132156 · Cited by 41
The associations between exercise and lipid biomarkers
Sulague, R. M., Suan, N. M., Mendoza, M. F., & Lavie, C. J. (2022) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2022.11.004 · Cited by 32
Bosco, G., Barbagallo, F. D. G., Marco, M. D., Scilletta, S., Miano, N., Capuccio, S., Musmeci, M., Mauro, S. D., Filippello, A., Scamporrino, A., et al. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.12.002 · Cited by 28
Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease
Lee, Y., Lee, S. J., Kim, J. W., Lee, S., Kim, G.-S., Park, J. H., Cho, J., Kang, W. C., Yoon, H., Kim, W., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2600283 · Cited by 37
Kjeldsen, E. W., Thomassen, J. Q., Rasmussen, K. L., Nordestgaard, B. G., Tybjærg‐Hansen, A., & Frikke‐Schmidt, R. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100419 · Cited by 30
Lipid-lowering Therapy and Coronary Plaque Regression
Ueki, Y., Itagaki, T., & Kuwahara, K. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv22024 · Cited by 28
Lambadiari, V., Korakas, E., & Tsimihodimos, V. (2020) · Nutrients · doi:10.3390/nu12082204 · Cited by 29
Dell’Anno, M., Reggi, S., Caprarulo, V., Hejna, M., Rossi, C. A. S., Callegari, M. L., Baldi, A., & Rossi, L. (2021) · Animals · doi:10.3390/ani11061693 · Cited by 27
Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland
Björnsson, E., Þorgeirsson, G., Helgadóttir, A., Þorleifsson, G., Sveinbjörnsson, G., Kristmundsdóttir, S., Jónsson, H., Jónasdóttir, A., Jónasdóttir, Á., Sigurðsson, Á., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315904 · Cited by 27
Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease
Belch, J. J. F., Brodmann, M., Baumgärtner, I., Binder, C. J., Casula, M., Heiß, C., Kahan, T., Parini, P., Poredoš, P., Catapano, A. L., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.09.022 · Cited by 27
Self-citationPoli, A., Catapano, A. L., Corsini, A., Manzato, E., Werba, J. P., Catena, G., Cetin, I., Cicero, A. F. G., Cignarella, A., Colivicchi, F., et al. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.10.001 · Cited by 27
Self-citation
Metadata
- Authors
- Ference, B. A., Graham, I., Tokgozoglu, L., & Catapano, A. L.
- Affiliations
- University of Cambridge (GB)
- Trinity College Dublin (IE)
- University of Milan (IT)
- Corresponding author
- Catapano, Alberico L.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 72
- Issue
- 10
- Pages
- 1141-1156
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2889378692
- Cited by
- 511
- References
- 62
- Citations by year
- 2026: 65 · 2025: 75 · 2024: 82 · 2023: 80 · 2022: 68 · 2021: 76 · 2020: 35 · 2019: 29 · 2018: 1
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- ideal cardiovascular health, cardiovascular disease prevention, atherosclerosis, atherogenic lipoproteins, serum lipids, cardiovascular risk, care pathways
- MeSH terms
- Hypolipidemic Agents, Cardiovascular Diseases, Diet, Health Promotion, Humans, Lipids, Cholesterol, LDL, Primary Prevention, Genetic Variation, Exercise, Disease Progression, Genetic Predisposition to Disease, Atherosclerosis, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
